effective – Physicence.com

A common anti-anxiety pill taken by 16 million Americans isn’t very effective and its effectiveness has been greatly exaggerated, according to a Harvard analysis.

October 24, 2023 by Paul

Xanax, also known as alprazolam, was approved by the FDA in 1981 and belongs to the benzodiazepine class, a group of depressant medications used to relieve anxiety.

It’s known to be addictive, harmful to the body, and carries the risk of overdose — and now scientists say Xanax might not even be that effective. Researchers from Harvard University and Oregon Health & Science University re-examined trials and studies investigating the effectiveness of Xanax in treating panic disorder. They found several examples of …

Biosimilars: a cheaper and effective alternative to branded drugs

October 19, 2023 by Paul

The European Commission’s pharmaceutical reform would improve access to cheaper biosimilar medicines and speed up market access. Connie Ziegler was diagnosed with rheumatoid arthritis when she was a young girl. “When I was about a year and a half old, my parents told me that my knees were starting to hurt especially. And that I …

I Swapped Situps for These Five Kettlebell Moves and Enjoyed a Much More Effective Core Workout

October 16, 2023 by Paul

Receive the Fit&Well newsletter Start your week with actionable workout ideas, health tips, and wellness advice in your inbox. Thank you for subscribing to Fit And Well. You will receive a verification email shortly. There was a problem. Refresh the page and try again. By submitting your information you agree to the Terms and Conditions …

Narcolepsy medication may be effective for ADHD in adults

October 11, 2023 by Paul

An already approved drug for excessive daytime sleepiness may help relieve symptoms of attention-deficit/hyperactivity disorder (ADHD) in adults that aren’t relieved by available treatments, according to a small pilot study. Solriamfetol is a non-stimulant medication approved for the treatment of drowsiness caused by narcolepsy (sudden sleep attacks) and obstructive sleep apnea (marked by interruptions in …

Low-dose glucocorticoids for long-term control of AAV as effective as…

October 9, 2023 by Paul

A combination regimen of low-dose glucocorticoids and rituximab is just as effective in controlling ANCA-associated vasculitis (AAV) as a standard regimen of high-dose glucocorticoids and rituximab, according to data from a clinical trial of two years. Long-term results indicate that although effectiveness is comparable, the risk of serious side effects is significantly reduced with the …